Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dunford

Showing results (771-780 of 1,091) with videos related to

Pageof 110
Sort By:
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regionsIvan C Rokos, William J French, William J Koenig, et al.
Cancer Discovery|December 8, 2022
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma PathologyAnkit K Dutta, Jean-Baptiste Alberge, Elizabeth D Lightbody, et al.
Circulation|September 15, 2017
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo)Peter J Kudenchuk, Brian G Leroux, Mohamud Daya, et al.
Nature Communications|June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomesMark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.
European Journal of Preventive Cardiology|October 6, 2011
International collaborative project to compare and monitor the nutritional composition of processed foodsElizabeth Dunford, Jacqui Webster, Adriana Blanco Metzler, et al.
Blood Cancer Journal|January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.
The New England Journal of Medicine|April 5, 2016
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac ArrestPeter J Kudenchuk, Siobhan P Brown, Mohamud Daya, et al.
The Lancet. Oncology|October 10, 2025
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysisDaniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, et al.
Pageof 110

Showing results (771-780 of 1,091) with videos related to

Sort By:
Pageof 110
Blood|March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomasJames Heward, Lola Konali, Annalisa D'Avola, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regionsIvan C Rokos, William J French, William J Koenig, et al.
Cancer Discovery|December 8, 2022
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma PathologyAnkit K Dutta, Jean-Baptiste Alberge, Elizabeth D Lightbody, et al.
Circulation|September 15, 2017
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo)Peter J Kudenchuk, Brian G Leroux, Mohamud Daya, et al.
Nature Communications|June 15, 2022
Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomesMark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis, et al.
European Journal of Preventive Cardiology|October 6, 2011
International collaborative project to compare and monitor the nutritional composition of processed foodsElizabeth Dunford, Jacqui Webster, Adriana Blanco Metzler, et al.
Blood Cancer Journal|January 11, 2023
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myelomaKeiji Kurata, Anna James-Bott, Mark A Tye, et al.
The New England Journal of Medicine|April 5, 2016
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac ArrestPeter J Kudenchuk, Siobhan P Brown, Mohamud Daya, et al.
The Lancet. Oncology|October 10, 2025
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysisDaniella Black, Helen Ruth Davies, Gene Ching Chiek Koh, et al.
Pageof 110